Cassava Sciences reported $-0.92 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
-0.92 Aug/14 2025



Eps Change Date
Abbott USD 1.26 0.17 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
Cassava Sciences USD -0.92 0.35 Jun/2025
Eisai JPY 51.35 47.73 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Geron USD -0.02 0.01 Jun/2025
J&J USD 2.77 0 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024